Still’s Disease Treatment Market, By Treatment, By Route of Administration, By Distribution Channels and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Still's disease, also known as Adult-onset Still's Disease (AOSD), is a rare inflammatory disease characterized by joint pain, rash, and fever. This devastating condition can lead to long-term chronic arthritis and permanent injuries. Still's disease is associated with a rash that does not itch and a high fever. This disorder can destroy the affected joints, especially the wrists. Treatment for Still's disease includes anti-inflammatory medications. Still's disease is a rare rheumatic disease. This disease is characterized by biological and clinical symptoms such as high fever, joint swelling, myalgia, sore throat, increase in white blood cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for Still's disease can be divided into two categories, namely symptomatic treatments and effective treatments. Symptomatic treatment can be started immediately even if the diagnosis is not confirmed, while effective treatment methods are designed to treat the disease more effectively to eliminate the symptoms of the disease.
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global Still’s disease treatment market growth. For instance, on April 13, 2023, Metropolis Healthcare noted that treatment of Still's disease with nonsteroidal anti-inflammatory drugs (NSAIDs), these medications reduce inflammatory pain and the signs and symptoms of Still’s disease. Corticosteroids reduce inflammation by reducing the activity of the immune system. Disease-modifying Antirheumatic Drugs (DMARDs) can help slow down the progress of Still’s disease and reduce the frequency of flares. Physical therapy, exercise, rest, and a healthy diet can help manage the condition and keep symptoms to a minimum.
Key features of the study:
This report provides an in-depth analysis of the global Still’s disease treatment market and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Still’s disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include AB2 Bio Ltd , F.offmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, and Fresenius Kabi AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Still’s disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Still’s disease treatment market
Detailed Segmentation:
Global Still’s Disease Treatment Market, By Treatment :
Pain Management
Corticosteroids
Tocilizumab
Canakinumab
Others
Global Still’s Disease Treatment Market, By Route of Administration :
Injectables
Oral
Global Still’s Disease Treatment Market, By Distribution Channels :
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Still’s Disease Treatment Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
AB2 Bio Ltd.
F.Hoffmann-La Roche Ltd
Novartis AG
Swedish Orphan Biovitrum AB
Jubilant Life Sciences Ltd
Vintage Labs
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd
Mylan N.V
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Amneal Pharmaceuticals LLC
Dr Reddy's Laboratories Ltd
Fresenius Kabi AG
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Treatment
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Still’s Disease Treatment Market – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Still’s Disease Treatment Market, By Treatment, 2018–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis,
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Tocilizumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Canakinumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
6. Global Still’s Disease Treatment Market, By Route of Administration, 2018–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Injectables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
7. Global Still’s Disease Treatment Market, By Distribution Channel, 2018–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Online Pharmacies
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
8. Global Still’s Disease Treatment Market, By Region, 2018–2030, (US$ Billion)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2018–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018–2030, (US$ Billion)
North Africa
Central Africa
South Africa
9. Competitive Landscape
AB2 Bio Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
F.Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Swedish Orphan Biovitrum AB
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Jubilant Life Sciences Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Vintage Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Horizon Therapeutics plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sun Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zydus Cadila
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amneal Pharmaceuticals LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Dr Reddy's Laboratories Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Fresenius Kabi AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 40 market data tables and 48 figures on “Global Still’s Disease Treatment Market”- Global forecast to 2030